Shkreli is still in prison after being convicted of securities fraud in 2017.
A federal judge ruled Friday morning that Martin Shkreli, a former hedge fund manager convicted of securities fraud in 2017, must pay $64.4 million in fines to states that filed an antitrust lawsuit over his dramatic increase to the price of Daraprim, a life-saving drug, in 2015.
